Patents by Inventor Xiaojian Han

Xiaojian Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL CORONAVIRUS RBD SPECIFIC MONOCLONAL ANTIBODY AND LINEAR EPITOPE AND APPLICATION THEREOF
    Publication number: 20230374115
    Abstract: The present disclosure belongs to the field of immune technology, and particularly discloses a SARS-CoV-2 RBD-specific monoclonal antibody including a heavy chain having an amino acid sequence set forth in SEQ ID NO: 1 and a light chain having an amino acid sequence set forth in SEQ ID NO: 2. The present disclosure further discloses a linear epitope of the SARS-CoV-2 RBD-specific monoclonal antibody having an amino acid sequence set forth in SEQ ID NO: 3. The SARS-CoV-2 RBD-specific monoclonal antibody and the linear epitope thereof of the present disclosure are critical for research and development of vaccines and micromolecule drugs, diagnosis, prevention and treatment of COVID-19.
    Type: Application
    Filed: February 17, 2023
    Publication date: November 23, 2023
    Inventors: Aishun Jin, Tingting Li, Xiaojian Han, Yingming Wang, Chao Hu, Shenglong Li, Jianwei Wang